Abbott Laboratories Stock
€108.88
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Abbott
sharewise wants to provide you with the best news and tools for Abbott, so we directly link to the best financial data sources.
Financials
News
Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield
If you wonder whether Abbott Laboratories (NYSE: ABT) is a good buy in Q2 2025, the answer is yes. The company’s management, portfolio, cash flow, capital return, and pipeline are why. The stock
Tariff-Resistant Abbott Laboratories on Track for New Highs
Abbott Laboratories (NYSE: ABT) is not immune to the impact of tariffs on its medical device business. However, the company’s diversified business is tariff-resistant, and moves are being made to
Abbott Laboratories Stock: CE Mark Boosts Cardiac Treatment Innovation
Abbott Laboratories recently experienced a significant upward breakthrough after receiving CE marking for its innovative Volt PFA system, designed to treat atrial fibrillation. This heart rhythm
Abbott Laboratories Stock: Executives Sell Shares Near 52-Week High
Abbott Laboratories is experiencing notable stock market activity as multiple senior executives recently divested portions of their holdings. Former Executive Vice President Andrea F. Wainer sold
Abbott Reports 10.5% EPS Growth for Fiscal Q2
Abbott Laboratories (NYSE:ABT), a global healthcare company known for its medical devices, diagnostics, nutrition, and pharmaceuticals, reported fiscal 2025 earnings on Thursday, July 17, that
Abbott (ABT) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Need a quote from one of our analysts? Email [email protected]
Abbott Laboratories (NYSE:ABT) presented a quarter marked by distinct segment divergence, with medical devices
2 Dividend Stocks to Buy With $500 and Hold Forever
Broader equities have been volatile this year, but that's par for the course. The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest. However
2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?
Investing in excellent dividend stocks can be a great strategy to mitigate risk and boost long-term returns. Companies that can dispense regular payouts to their shareholders -- especially those
3 Dividend Stocks to Buy and Hold for the Next Decade
Many income investors would love to have a low-maintenance portfolio that doesn't require constant attention. They'd prefer to buy great stocks and rake in the dividends without any hiccups.
Three
3 Relatively Safe Stocks to Buy Right Now
Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others during certain market conditions.
Three Motley Fool contributors think
Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday
Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe. Investors greeted this positively, rewarding the company with a
2 Unstoppable Dividend Stocks That Will Pay You for Life
In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As most income seekers want to avoid this fate, they might consider turning to